The development and impact of tuberculosis vaccines.
Vaccination is expected to make a major contribution to the goal of eliminating tuberculosis worldwide by 2050. But developing a new effective vaccine will require innovation in scientific research, a proactive approach to clinical trials of new vaccine candidates, and application of vaccines as part of an integrated approach to disease control.
Imperial College, University of London, South Kensington Campus, London SW7 2AZ, United Kingdom. d.young@imperial.ac.uk
Douglas
D
Young
Christopher
C
Dye
D000818:Animals; D001500:BCG Vaccine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D014943:Global Health; D006801:Humans; D017589:Immunization Programs; D015994:Incidence; D013678:Technology, Pharmaceutical; D014376:Tuberculosis / Q000453:epidemiology / Q000517:prevention & control*; D032581:Tuberculosis Vaccines / Q000276:immunology / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control; D017778:Vaccines, Combined
D001500:BCG Vaccine; D032581:Tuberculosis Vaccines; D017778:Vaccines, Combined